[ABO incompatible renal transplantation].
ABO-incompatible living donor renal transplantation began in 1982. It may provide a significant source of organs. One dose of rituximab is given four weeks pre-operatively and oral triple immunosuppressive regimen is introduced 7 days pre-operatively. Anti A/B titres are lowered to less than 1:8 by specific immunoadsorption with Glycosorb column. During the first 15 days post-transplant, accommodation state is acquired. Thereafter, graft and patient survivals, and acute humoral rejection rates are the same as those of ABO identical renal transplantations.
Service de transplantation, Département de chirurgie, HUG, 1211 Geneve 14. karine.hadaya@hcuge.ch
K
K
Hadaya
D000017:ABO Blood-Group System / Q000276:immunology; D000222:Adaptation, Physiological / Q000276:immunology / Q000502:physiology; D000906:Antibodies / Q000097:blood; D001787:Blood Group Incompatibility / Q000097:blood / Q000276:immunology; D005060:Europe; D006284:Health Plan Implementation / Q000379:methods; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D019520:Living Donors; D013557:Switzerland; D019172:Transplantation Conditioning / Q000379:methods
D000017:ABO Blood-Group System; D000906:Antibodies